| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Malignant Mesothelioma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Mesothelioma | |||||
| 3 | More general conditions related to this trial | ||||
| Adenoma | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Neoplasms, Mesothelial | |||||
| 4 | Interventions listed in this trial | ||||
| cisplatin | |||||
| mitomycin C | |||||
| vincristine sulfate | |||||
| vinorelbine ditartrate | |||||
| pain therapy | |||||
| psychosocial assessment and care | |||||
| quality-of-life assessment | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Mitomycin | |||||
| Vinblastine | |||||
| Vincristine | |||||
| Vinorelbine | |||||
| 6 | More general drug interventions related to this trial | ||||
| Alkylating Agents | |||||
| Antibiotics, Antineoplastic | |||||
| Antimitotic Agents | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Phytogenic | |||||
| Enzyme Inhibitors | |||||
| Mitosis Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Nucleic Acid Synthesis Inhibitors | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| Tubulin Modulators | |||||
| 7 | Sponsors listed in this trial | ||||
| Medical Research Council | |||||
|
